Research and Development

Stemming from a theory she developed as a sophomore at John Hopkins University in Maryland, Hasini Jayatilaka and a team …

Novartis has posted positive news from the Cantos clinical trial study that saw its drug, Canakinumab, pull of a surprise …

More drama in the Indian pharma sector as the FDA announces it has enforced a ban on the import of …

Shire has revealed that the FDA has approved its long-acting and interestingly named ADHD drug, Mydayis. The approval comes more …

Researchers from the University of Adelaide have linked a specific type of irritable bowel syndrome with the exhaustion of the …

Good news for Novo Nordisk as the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the FDA recommends that data …

Research emerging from the University of Utah Health has built on knowledge that drugs used in combination can be more …

Novartis has achieved positive feedback from its two Phase 3 studies into its eye drug RTH258 (brolucizumab), which found it …

After positive results for a ‘vaccine’ to combat fatty deposits in the arteries in mice, the researchers have taken the …

A potentially pivotal Phase 1 study has been launched by Pfizer into the use of its investigational vaccine as a …

Thermo Fisher Scientific Inc., the world leader in serving science, today announced new technologies that are designed to allow analytical …

A new study from Novartis has indicated that patients suffering from severe asthma still do not get adequate support to …

A significant step forward has been made in moving towards a treatment for neglected tropical disease mycetoma as the first-ever …

Pharmafocus caughtup with Lawrence Blatt, Janssen’s Global Therapeutic Area Head, Infectious Diseases and Vaccines, to discuss the progress being made in the …

Research emerging from scientists at the University of Notre Dame has found that exposing mosquitos to light during the night …